在产业领域，穗港马产业经济圈持续扩容。穗港依托从化马场共建世界级马产业经济圈，不仅打造占地 超150公顷、设施顶尖的马匹训练中心，更创新穗港赛马跨境运输通关，推动赛马在穗港两地"自由 行"，建立内地首个永久性、国际认可的无规定马属动物疫病区。 值得关注的是，今年初广州出台的服务消费专项措施提出了23条具体举措，107项工作任务，涉及商 务、文广旅、体育、卫健、教育、民政等多个领域。据介绍，下一步广州市商务局将会同有关部门和各 区围绕国际消费中心城市培育建设大力推进服务消费，持续优化服务消费供给，立足本土文化特色，对 接全球资源，形成供给优化、场景多元、环境友好的消费新格局。 数据显示，1—6月，广州全市规模以上营利性服务业实现营业收入同比增长8.7%。重点行业中，互联 网、软件和信息技术服务业增势良好，实现营业收入增长7.9%，租赁和商务服务业保持较快增速，增 长12.4%，科学研究和技术服务业增速稳步提升，增长5.3%，文体产业蓬勃发展，文化艺术业、体育业 分别增长9.7%和17.6%。 值得一提的是，作为粤港澳大湾区核心引擎，广州聚焦民生与经济跨境需求，推动"制度之异"转化 为"协同之利"。在医疗领域，" ...

每经AI快讯，美好医疗（SZ 301363，收盘价：25.84元）9月15日晚间发布公告称，公司第二届第二十 一次董事会会议于2025年9月15日在公司会议室以现场结合通讯方式召开。会议审议了《关于续聘2025 年度会计师事务所的议案》等文件。 截至发稿，美好医疗市值为147亿元。 每经头条（nbdtoutiao）——重大突破！中国这款新药，中美官方都认定有突破性疗效！世界肺癌大会 沸腾了 （记者 曾健辉） 2024年1至12月份，美好医疗的营业收入构成为：医疗占比84.23%，非医疗占比15.77%。 ...

创新医疗今日下跌7.16%，全天换手率26.01%，成交额24.78亿元，振幅8.49%。龙虎榜数据显示，机构 净卖出1.71亿元，营业部席位合计净买入5037.54万元。 深交所公开信息显示，当日该股因日跌幅偏离值达-10.35%上榜，机构专用席位净卖出1.71亿元。 资金流向方面，今日该股主力资金净流出2.37亿元，其中，特大单净流出1.32亿元，大单资金净流出 1.05亿元。近5日主力资金净流出3230.67万元。（数据宝） 创新医疗9月5日交易公开信息 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 方正证券股份有限公司深圳翔鸽路证券营业部 | 6576.18 | 5233.28 | | 买二 | 国信证券股份有限公司浙江互联网分公司 | 3194.34 | 1826.62 | | 买三 | 东方财富证券股份有限公司拉萨金融城南环路证券营业 部 | 3005.88 | 2328.16 | | 买四 | 东方财富证券股份有限公司拉萨东环路第二证券营业部 | 2974.73 | 20 ...

Group 1 - The company is closely monitoring the application and development of cutting-edge technologies such as brain-computer interfaces in the healthcare sector [2] - The company evaluates all potential collaboration opportunities from multiple dimensions including strategic alignment, technical feasibility, economic benefits, and risk control [2]

Core Viewpoint - Tianyuan Medical (00557) reported a significant decline in revenue and a reduced loss for the six months ending June 30, 2025, indicating ongoing financial challenges but some improvements in loss management [1] Financial Performance - The company achieved a revenue of HKD 8.436 million, representing a year-on-year decrease of 43.23% [1] - The loss attributable to equity holders was HKD 3.065 million, which is a reduction of 45.33% compared to the previous year [1] - The loss per share was HKD 0.77 [1] Loss Management - The reduction in loss was primarily due to a decrease in realized and unrealized valuation losses on securities by approximately HKD 600,000 [1] - The company reversed expected credit losses of about HKD 2.5 million during the period [1] - There was a significant turnaround in foreign exchange losses, with a previous loss of approximately HKD 1.9 million turning into a gain of about HKD 2.7 million [1] - Total revenue decline was offset by a reduction of approximately HKD 6.4 million [1]

Financial Performance - The company's total revenue for the first half of 2025 was 314 million yuan, ranking 39th among disclosed peers, representing a decrease of 68.37 million yuan or 17.90% year-on-year [1] - The net profit attributable to shareholders was -23.75 million yuan, ranking 44th among disclosed peers, a decrease of 24.30 million yuan or 4391.18% year-on-year [1] - The net cash flow from operating activities was -27.59 million yuan, ranking 43rd among disclosed peers, a decrease of 34.59 million yuan or 494.15% year-on-year [1] Financial Ratios - The latest debt-to-asset ratio was 71.73%, ranking 47th among disclosed peers, an increase of 0.64 percentage points from the previous quarter and 2.00 percentage points year-on-year [3] - The latest gross profit margin was 43.16%, ranking 18th among disclosed peers, an increase of 4.65 percentage points from the previous quarter but a decrease of 2.90 percentage points year-on-year [3] - The latest return on equity (ROE) was -6.37%, ranking 48th among disclosed peers, a decrease of 6.50 percentage points year-on-year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share was -0.03 yuan, ranking 41st among disclosed peers, a decrease of 0.03 yuan or 4142.86% year-on-year [3] - The latest total asset turnover ratio was 0.21 times, ranking 25th among disclosed peers, a decrease of 0.03 times or 13.82% year-on-year [3] - The latest inventory turnover ratio was 3.43 times, ranking 23rd among disclosed peers, an increase of 0.16 times, marking five consecutive years of growth, and an increase of 4.91% year-on-year [3]

Group 1 - The company, Purui Eye Hospital, announced on August 28 that it is applying for bank credit guarantees for its wholly-owned subsidiary, with a total external guarantee amount of approximately 765 million RMB, which includes this application [1] - The total external guarantee balance is approximately 548 million RMB, accounting for 26.1% of the company's audited net assets for the year 2024 [1] - For the fiscal year 2024, the company's revenue composition shows that the medical industry accounts for 99.31% of its total revenue, while other businesses contribute 0.69% [1] Group 2 - As of the report date, the market capitalization of Purui Eye Hospital is 6.4 billion RMB [2]

智通财经APP讯，GUANZE MEDICAL(02427)发布截至2025年6月30日止6个月业绩，该集团期内取得收 入3185.5万元人民币，同比减少20.42%;公司拥有人应占溢利336.8万元，同比扭亏为盈;每股基本盈利 0.003元。 ...

Core Viewpoint - The company, Sely Medical, announced that its stock price has deviated significantly, with a cumulative increase of over 20% in the last three trading days, indicating abnormal trading fluctuations [1] Company Operations - The company conducted a self-examination and confirmed that all production and operational activities are normal [1] - There have been no significant changes in the market environment or industry policies affecting the company [1] - The internal production and operational order remains normal [1] Disclosure of Information - The company stated that there are no major events that could impact the abnormal fluctuations in stock trading prices [1] - There are no undisclosed significant information that should have been disclosed [1]

Group 1 - The stock of Saily Medical (603716) increased by 4.99% with a turnover rate of 37.04% and a trading volume of 2.592 billion yuan, showing a volatility of 10.17% [2] - The stock was listed on the Shanghai Stock Exchange's daily trading list due to a turnover rate of 33.66%, with a net buying amount of 146 million yuan from brokerage seats [2] - In the last six months, the stock has appeared on the trading list 32 times, with an average price increase of 2.06% the next day and an average increase of 7.23% over five days after being listed [2] Group 2 - The company reported a first-quarter revenue of 287 million yuan, a year-on-year decrease of 40.75%, and a net loss of 14.32 million yuan [2] - On July 15, the company released a half-year performance forecast, expecting a net loss between 66 million yuan and 55 million yuan, representing a year-on-year change of -1282.92% to -1052.44% [3] - The top five buying and selling brokerage seats on August 26 included Guotai Junan Securities Headquarters, CITIC Securities Shanghai Branch, and UBS Securities, with significant buying and selling amounts [3][4]